Launch of a new acceleration programme, Impact4kids, driven by Impact1 and i4KIDS, which aims to accelerate disruptive technology solutions in foetal, paediatric and maternal health and foster collaboration between innovators on both sides of the Atlantic.
Featured
The report, published by the i4KIDS-EUROPE consortium, examines the state of pediatric innovation and includes recommendations to boost the pediatric and maternal health innovation sector in Europe. Increasing public and private investment, easing regulations, facilitating the adoption of innovation, and supporting the creation of pediatric innovation infrastructures in hospitals are among the proposals.
Read more
Featured
Gate2Brain receives EMA Orphan Drug Designation for pioneering treatment of paediatric brain tumours
The European Medicines Agency (EMA) has awarded Orphan Drug Designation (ODD) to G2B-002, an innovative therapeutic candidate for the treatment of aggressive paediatric brain tumours, including diffuse intrinsic pontine glioma (DIPG) and paediatric glioblastoma (pGBM), developeb by gate2Brain, a spin-off from the Sant Joan de Déu Barcelona Children's Hospital.
After the Pediatric Innovation Day held in Riga last September, i4KIDS celebrates an extraordinary edition in Barcelona of this event of reference in innovation in paediatric, foetal and maternal health, which is consolidated as a meeting and reflection point for the innovative community in paediatrics.
Featured
The second i4KIDS International Mission on Paediatric Innovation in Riga was a key activity to foster collaboration and synergies in the fetal, paediatric and maternal health sector. Six members of the i4KIDS network had the opportunity to make institutional visits and meet with public-private entities of the paediatric innovation ecosystem of Latvia.
Featured
Sencilia, winner of the i4KIDS-EUROPE Hospital Challenge Programme 2024 for its innovative solution in paediatric medication risk monitoring. The final of this contest was held in Riga, during the Pediatric Innovation Day 2024.
Featured
Pediatric Innovation Day 2024 brings together professionals from the European paediatric innovation ecosystem in Riga for a programme based on the challenges and opportunities that the sector offers to boost the well-being of paediatric patients.
Featured
i4KIDS-4RARE, a new European project born as a specific programme of i4KIDS, the Paediatric Innovation Hub coordinated by Sant Joan de Déu Barcelona Children's Hospital and Fundació de Recerca Sant Joan de Déu focused on rare diseases and orphan medical devices for paediatric patients.
Featured
The i4KIDS 2024 Acceleration Programme, designed to identify and guide innovative projects in fetal, paediatric, and maternal health, has already selected the five participants who will complete a training and mentoring process from July to November this year. The programme will culminate in the Pediatric Innovation Day, which will be held in Barcelona on November 21, with a grand final presentation.
Open call for participation in the i4KIDS 2024 International Mission to Riga on innovation in fetal, paediatric and maternal health for i4KIDS members.
Featured
Technology companies with innovative solutions aimed at improving the management and efficiency of paediatric hospitals can apply for the i4KIDS-EUROPE "Hospital Challenge 2024" programme. The final will take place at the Pediatric Innovation Day 2024 in Riga on 27 September.
Featured
i4KIDS participates in the 4YFN in the framework of the Mobile World Congress 2024 with the aim of driving innovation in the field of foetal, paediatric and maternal health.
Featured
Flu-Copilot, the AI assistant developed by Arkangel AI, is the winning solution of the Pediatric Innovation Challenge organised by i4KIDS and AstraZeneca to help to reduce the burden of paediatric influenza on society.